APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Pulmonary Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174002830329 December 2025191 pages

Choose your research edition.

Industry ResearchInhalation Pulmonary Drug Delivery Devices Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhalation Pulmonary Drug Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Pulmonary Drug Delivery Devices include AptarGroup, Boehringer Ingelheim, Chiesi Farmaceutici, H&T Presspart, Koninklijke Philips, Monaghan Medical, OMRON, PARI International and Vectura, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Pulmonary Drug Delivery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Pulmonary Drug Delivery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Pulmonary Drug Delivery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Pulmonary Drug Delivery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Pulmonary Drug Delivery Devices Segment by Company

AptarGroup

Boehringer Ingelheim

Chiesi Farmaceutici

H&T Presspart

Koninklijke Philips

Monaghan Medical

OMRON

PARI International

Vectura

AstraZeneca

GlaxoSmithKline (GSK)

Viatris

Merck

Novartis

Teva Pharmaceutical Industries

Inhalation Pulmonary Drug Delivery Devices Segment by Type

Nebulizers

Dry-powder Inhalers

Metered- dose Inhalers

Inhalation Pulmonary Drug Delivery Devices Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhalation Pulmonary Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Pulmonary Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Pulmonary Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Pulmonary Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Pulmonary Drug Delivery Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalation Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalation Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalation Pulmonary Drug Delivery Devices Industry Trends Table 2. Inhalation Pulmonary Drug Delivery Devices Industry Drivers Table 3. Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges Table 4. Inhalation Pulmonary Drug Delivery Devices Industry Restraints Table 5. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalation Pulmonary Drug Delivery Devices Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers Table 9. Global Inhalation Pulmonary Drug Delivery Devices Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhalation Pulmonary Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers, Product Type & Application Table 13. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Pulmonary Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nebulizers Table 17. Major Manufacturers of Dry-powder Inhalers Table 18. Major Manufacturers of Metered- dose Inhalers Table 19. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 21. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 22. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 23. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 24. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 28. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Chronic Obstructive Pulmonary Disease (COPD) Table 30. Major Manufacturers of Cystic Fibrosis (CF) Table 31. Major Manufacturers of Idiopathic Pulmonary Fibrosis (IPF) Table 32. Major Manufacturers of Asthma Table 33. Major Manufacturers of Others Table 34. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 36. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 37. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 38. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 39. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (K Units) Table 41. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (K Units) Table 42. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 43. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 44. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 46. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 47. Global Inhalation Pulmonary Drug Delivery Devices Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Inhalation Pulmonary Drug Delivery Devices Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 51. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 52. Europe Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 54. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 61. Global Inhalation Pulmonary Drug Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 65. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 66. AptarGroup Company Information Table 67. AptarGroup Business Overview Table 68. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 70. AptarGroup Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Chiesi Farmaceutici Company Information Table 77. Chiesi Farmaceutici Business Overview Table 78. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 80. Chiesi Farmaceutici Recent Development Table 81. H&T Presspart Company Information Table 82. H&T Presspart Business Overview Table 83. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 85. H&T Presspart Recent Development Table 86. Koninklijke Philips Company Information Table 87. Koninklijke Philips Business Overview Table 88. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 90. Koninklijke Philips Recent Development Table 91. Monaghan Medical Company Information Table 92. Monaghan Medical Business Overview Table 93. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 95. Monaghan Medical Recent Development Table 96. OMRON Company Information Table 97. OMRON Business Overview Table 98. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 100. OMRON Recent Development Table 101. PARI International Company Information Table 102. PARI International Business Overview Table 103. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 105. PARI International Recent Development Table 106. Vectura Company Information Table 107. Vectura Business Overview Table 108. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 110. Vectura Recent Development Table 111. AstraZeneca Company Information Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 115. AstraZeneca Recent Development Table 116. GlaxoSmithKline (GSK) Company Information Table 117. GlaxoSmithKline (GSK) Business Overview Table 118. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 120. GlaxoSmithKline (GSK) Recent Development Table 121. Viatris Company Information Table 122. Viatris Business Overview Table 123. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 125. Viatris Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 130. Merck Recent Development Table 131. Novartis Company Information Table 132. Novartis Business Overview Table 133. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 135. Novartis Recent Development Table 136. Teva Pharmaceutical Industries Company Information Table 137. Teva Pharmaceutical Industries Business Overview Table 138. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 140. Teva Pharmaceutical Industries Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Inhalation Pulmonary Drug Delivery Devices Distributors List Table 144. Inhalation Pulmonary Drug Delivery Devices Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Inhalation Pulmonary Drug Delivery Devices Product Image Figure 2. Global Inhalation Pulmonary Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Pulmonary Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nebulizers Image Figure 9. Dry-powder Inhalers Image Figure 10. Metered- dose Inhalers Image Figure 11. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 14. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 17. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 18. Cystic Fibrosis (CF) Image Figure 19. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 20. Asthma Image Figure 21. Others Image Figure 22. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 25. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 28. North America Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 30. U.S. Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 35. Germany Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 42. China Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 50. Brazil Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Inhalation Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Inhalation Pulmonary Drug Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 61. North America Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 63. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Inhalation Pulmonary Drug Delivery Devices Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhalation Pulmonary Drug Delivery Devices Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nebulizers
  • Dry-powder Inhalers
  • Metered- dose Inhalers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • AptarGroup
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • H&T Presspart
  • Koninklijke Philips
  • Monaghan Medical
  • OMRON
  • PARI International
  • Vectura
  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Viatris
  • Merck
  • Novartis
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalation Pulmonary Drug Delivery Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalation Pulmonary Drug Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalation Pulmonary Drug Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalation Pulmonary Drug Delivery Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalation Pulmonary Drug Delivery Devices Market Dynamics
  1. 2.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
  2. 2.2 Inhalation Pulmonary Drug Delivery Devices Industry Drivers
  3. 2.3 Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Inhalation Pulmonary Drug Delivery Devices Industry Restraints
3 Inhalation Pulmonary Drug Delivery Devices Market by Manufacturers
  1. 3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalation Pulmonary Drug Delivery Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalation Pulmonary Drug Delivery Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Pulmonary Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers, Product Type & Application
  7. 3.7 Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Pulmonary Drug Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Pulmonary Drug Delivery Devices Tier 1, Tier 2, and Tier 3
4 Inhalation Pulmonary Drug Delivery Devices Market by Type
  1. 4.1 Inhalation Pulmonary Drug Delivery Devices Type Introduction
  2. 4.1.1 Nebulizers
  3. 4.1.2 Dry-powder Inhalers
  4. 4.1.3 Metered- dose Inhalers
  5. 4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type
  6. 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  8. 4.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type
  10. 4.3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032)
5 Inhalation Pulmonary Drug Delivery Devices Market by Application
  1. 5.1 Inhalation Pulmonary Drug Delivery Devices Application Introduction
  2. 5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
  3. 5.1.2 Cystic Fibrosis (CF)
  4. 5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
  5. 5.1.4 Asthma
  6. 5.1.5 Others
  7. 5.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application
  8. 5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  10. 5.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032)
  11. 5.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application
  12. 5.3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  14. 5.3.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032)
6 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region
  1. 6.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region
  1. 7.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region
  2. 7.1.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032)
  8. 7.2.2 North America Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032)
  11. 7.3.2 Europe Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AptarGroup
  2. 8.1.1 AptarGroup Company Information
  3. 8.1.2 AptarGroup Business Overview
  4. 8.1.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  6. 8.1.5 AptarGroup Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Chiesi Farmaceutici
  14. 8.3.1 Chiesi Farmaceutici Company Information
  15. 8.3.2 Chiesi Farmaceutici Business Overview
  16. 8.3.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  18. 8.3.5 Chiesi Farmaceutici Recent Developments
  19. 8.4 H&T Presspart
  20. 8.4.1 H&T Presspart Company Information
  21. 8.4.2 H&T Presspart Business Overview
  22. 8.4.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  24. 8.4.5 H&T Presspart Recent Developments
  25. 8.5 Koninklijke Philips
  26. 8.5.1 Koninklijke Philips Company Information
  27. 8.5.2 Koninklijke Philips Business Overview
  28. 8.5.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  30. 8.5.5 Koninklijke Philips Recent Developments
  31. 8.6 Monaghan Medical
  32. 8.6.1 Monaghan Medical Company Information
  33. 8.6.2 Monaghan Medical Business Overview
  34. 8.6.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  36. 8.6.5 Monaghan Medical Recent Developments
  37. 8.7 OMRON
  38. 8.7.1 OMRON Company Information
  39. 8.7.2 OMRON Business Overview
  40. 8.7.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  42. 8.7.5 OMRON Recent Developments
  43. 8.8 PARI International
  44. 8.8.1 PARI International Company Information
  45. 8.8.2 PARI International Business Overview
  46. 8.8.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  48. 8.8.5 PARI International Recent Developments
  49. 8.9 Vectura
  50. 8.9.1 Vectura Company Information
  51. 8.9.2 Vectura Business Overview
  52. 8.9.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  54. 8.9.5 Vectura Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 GlaxoSmithKline (GSK)
  62. 8.11.1 GlaxoSmithKline (GSK) Company Information
  63. 8.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 8.11.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  66. 8.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 8.12 Viatris
  68. 8.12.1 Viatris Company Information
  69. 8.12.2 Viatris Business Overview
  70. 8.12.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  72. 8.12.5 Viatris Recent Developments
  73. 8.13 Merck
  74. 8.13.1 Merck Company Information
  75. 8.13.2 Merck Business Overview
  76. 8.13.3 Merck Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  78. 8.13.5 Merck Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Teva Pharmaceutical Industries
  86. 8.15.1 Teva Pharmaceutical Industries Company Information
  87. 8.15.2 Teva Pharmaceutical Industries Business Overview
  88. 8.15.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  90. 8.15.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Pulmonary Drug Delivery Devices Value Chain Analysis
  2. 9.1.1 Inhalation Pulmonary Drug Delivery Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Pulmonary Drug Delivery Devices Production Mode & Process
  6. 9.2 Inhalation Pulmonary Drug Delivery Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Pulmonary Drug Delivery Devices Distributors
  9. 9.2.3 Inhalation Pulmonary Drug Delivery Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst